Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients
/in Dendritic Cells, International Publications, Malignant MelanomaAndrogen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization
/in Dendritic Cells, International Publications, Prostate CancerSynergistic effect of dendritic cell vaccination and anti-CD20 antibody treatment in the therapy of murine lymphoma
/in Dendritic Cells, International Publications, Malignant LymphomaEffect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines
/in Hyperthermia, International Publications, Pancreatic CancerAntitumor vaccines, immunotherapy and the immunological constant of rejection
/in Dendritic Cells, International PublicationsConditioning vaccination site with irradiated MIP-3alpha-transfected tumor cells enhances efficacy of dendritic cell-based cancer vaccine
/in Dendritic Cells, International PublicationsMelanoma vaccines: The problems of local immunosuppression
/in International Publications, Malignant Melanoma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer